Target-mediated drug metabolic characteristics of TCP-1，a novel peptide to diagnose early colorectal cancer

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-A-019-Tuesday
• By: FENG, Ru (Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China)
• Co-author(s): Bao-Ying Wen: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  Ru Feng: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  Min Huang: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  Yan Wang: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  
• Abstract:

  Backgrounds

  A nine cyclic peptide (TCP-1) showed an excellent specificity to colorectal cancer with diameter as small as 2 mm in our previous work.

  Aims

  To study the target-mediated metabolic characteristics and the specificity to colorectal cancer (CRC) of the new peptide TCP-1. 

  Methods

  Pharmacokinetics of TCP-1 in both mice and tumor-bearing mice
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login